rs1135640

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_004035.7(ACOX1):​c.936C>G​(p.Ile312Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.644 in 1,613,296 control chromosomes in the GnomAD database, including 343,514 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 26185 hom., cov: 31)
Exomes 𝑓: 0.65 ( 317329 hom. )

Consequence

ACOX1
NM_004035.7 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.13

Publications

47 publications found
Variant links:
Genes affected
ACOX1 (HGNC:119): (acyl-CoA oxidase 1) The protein encoded by this gene is the first enzyme of the fatty acid beta-oxidation pathway, which catalyzes the desaturation of acyl-CoAs to 2-trans-enoyl-CoAs. It donates electrons directly to molecular oxygen, thereby producing hydrogen peroxide. Defects in this gene result in pseudoneonatal adrenoleukodystrophy, a disease that is characterized by accumulation of very long chain fatty acids. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ACOX1 Gene-Disease associations (from GenCC):
  • peroxisomal acyl-CoA oxidase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics, Orphanet
  • Mitchell syndrome
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_004035.7
BP4
Computational evidence support a benign effect (MetaRNN=1.0736948E-6).
BP6
Variant 17-75953459-G-C is Benign according to our data. Variant chr17-75953459-G-C is described in ClinVar as Benign. ClinVar VariationId is 259223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.768 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACOX1NM_004035.7 linkc.936C>G p.Ile312Met missense_variant Exon 7 of 14 ENST00000293217.10 NP_004026.2 Q15067-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACOX1ENST00000293217.10 linkc.936C>G p.Ile312Met missense_variant Exon 7 of 14 1 NM_004035.7 ENSP00000293217.4 Q15067-2

Frequencies

GnomAD3 genomes
AF:
0.549
AC:
83314
AN:
151894
Hom.:
26185
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.221
Gnomad AMI
AF:
0.677
Gnomad AMR
AF:
0.663
Gnomad ASJ
AF:
0.599
Gnomad EAS
AF:
0.789
Gnomad SAS
AF:
0.658
Gnomad FIN
AF:
0.763
Gnomad MID
AF:
0.532
Gnomad NFE
AF:
0.658
Gnomad OTH
AF:
0.559
GnomAD2 exomes
AF:
0.653
AC:
164061
AN:
251322
AF XY:
0.655
show subpopulations
Gnomad AFR exome
AF:
0.209
Gnomad AMR exome
AF:
0.714
Gnomad ASJ exome
AF:
0.609
Gnomad EAS exome
AF:
0.800
Gnomad FIN exome
AF:
0.766
Gnomad NFE exome
AF:
0.659
Gnomad OTH exome
AF:
0.644
GnomAD4 exome
AF:
0.654
AC:
955479
AN:
1461284
Hom.:
317329
Cov.:
55
AF XY:
0.654
AC XY:
475497
AN XY:
726972
show subpopulations
African (AFR)
AF:
0.202
AC:
6771
AN:
33470
American (AMR)
AF:
0.708
AC:
31646
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.605
AC:
15813
AN:
26118
East Asian (EAS)
AF:
0.752
AC:
29817
AN:
39668
South Asian (SAS)
AF:
0.646
AC:
55664
AN:
86222
European-Finnish (FIN)
AF:
0.758
AC:
40448
AN:
53378
Middle Eastern (MID)
AF:
0.502
AC:
2890
AN:
5758
European-Non Finnish (NFE)
AF:
0.660
AC:
734198
AN:
1111612
Other (OTH)
AF:
0.633
AC:
38232
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
17965
35929
53894
71858
89823
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18982
37964
56946
75928
94910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.548
AC:
83324
AN:
152012
Hom.:
26185
Cov.:
31
AF XY:
0.559
AC XY:
41545
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.221
AC:
9172
AN:
41478
American (AMR)
AF:
0.664
AC:
10107
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.599
AC:
2071
AN:
3458
East Asian (EAS)
AF:
0.789
AC:
4079
AN:
5172
South Asian (SAS)
AF:
0.657
AC:
3165
AN:
4818
European-Finnish (FIN)
AF:
0.763
AC:
8075
AN:
10580
Middle Eastern (MID)
AF:
0.537
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
0.658
AC:
44710
AN:
67970
Other (OTH)
AF:
0.554
AC:
1171
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1608
3216
4823
6431
8039
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
712
1424
2136
2848
3560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.635
Hom.:
23657
Bravo
AF:
0.525
TwinsUK
AF:
0.649
AC:
2408
ALSPAC
AF:
0.658
AC:
2535
ESP6500AA
AF:
0.235
AC:
1034
ESP6500EA
AF:
0.649
AC:
5582
ExAC
AF:
0.642
AC:
77994
Asia WGS
AF:
0.665
AC:
2311
AN:
3478
EpiCase
AF:
0.644
EpiControl
AF:
0.638

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Acyl-CoA oxidase deficiency Benign:5
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Oct 22, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mitchell syndrome Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
20
DANN
Benign
0.92
DEOGEN2
Benign
0.32
.;T
Eigen
Benign
-0.066
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.73
T;T
MetaRNN
Benign
0.0000011
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.7
L;L
PhyloP100
1.1
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-0.57
N;N
REVEL
Benign
0.13
Sift
Benign
0.26
T;T
Sift4G
Benign
0.19
T;T
Polyphen
0.0070
B;B
Vest4
0.28
MPC
0.65
ClinPred
0.012
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.041
gMVP
0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1135640; hg19: chr17-73949540; COSMIC: COSV53135078; COSMIC: COSV53135078; API